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Protein structure regulates expression <p>A proteomic association study between protein three-dimensional structure and transcriptional and post-transcriptional regulation in  yeast and human.</p>
Abstract
Background:  Gene co-expressions often determine module-defining spatial and temporal
concurrences of proteins. Yet, little effort has been devoted to tracing coordinating signals for
expression correlations to the three-dimensional structures of gene products.
Results: We performed a global structure-based analysis of the yeast and human proteomes and
contrasted this information against their respective transcriptome organizations obtained from
comprehensive microarray data. We show that protein vulnerability quantifies dosage sensitivity
for metabolic adaptation phases and tissue-specific patterns of mRNA expression, determining the
extent of co-expression similarity of binding partners. The role of protein intrinsic disorder in
transcriptome organization is also delineated by interrelating vulnerability, disorder propensity and
co-expression patterns. Extremely vulnerable human proteins are shown to be subject to severe
post-transcriptional regulation of their expression through significant micro-RNA targeting, making
mRNA levels poor surrogates for protein-expression levels. By contrast, in yeast the expression
of extremely under-wrapped proteins is likely regulated through protein aggregation. Thus, the 85
most vulnerable proteins in yeast include the five confirmed prions, while in human, the genes
encoding extremely vulnerable proteins are predicted to be targeted by microRNAs. Hence, in
both vastly different organisms protein vulnerability emerges as a structure-encoded signal for
post-transcriptional regulation.
Conclusion: Vulnerability of protein structure and the concurrent need to maintain structural
integrity are shown to quantify dosage sensitivity, compelling gene expression patterns across
tissue types and temporal adaptation phases in a quantifiable manner. Extremely vulnerable
proteins impose additional constraints on gene expression: They are subject to high levels of
regulation at the post-transcriptional level.
Background
The coordination of protein roles to achieve specific biological
functions requires the spatial/temporal concurrence of pro-
teins so that they can form complexes [1,2] or, in general,
operate within a module [2-4]. In turn, this concurrence is
tightly coordinated through the regulation of gene expres-
sion, as suggested by established correlations between the
transcriptome and the interactome [5,6]. However, structure-
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encoded factors that may quantitatively control such correla-
tions have not been identified. So far, protein structure has
not provided organizing clues for the integration of large-
scale descriptions of the molecular phenotype.
As reported in this work, by exploiting a structure-based anal-
ysis of protein associations [7,8] and their correlated expres-
sion patterns, we identify a structural attribute, protein
vulnerability, and show that it commits gene expression pat-
terns in a quantifiable manner. More specifically, protein vul-
nerability is shown to determine the extent of co-expression
of genes containing protein-encoding interactive domains in
metabolic adaptation phases [9,10] or tissue types [11,12],
while extreme vulnerability promotes significant post-tran-
scriptional regulatory control.
Soluble proteins maintain the integrity of their functional
structures provided the amide and carbonyl groups paired
through hydrogen bonds are adequately shielded from water
attack, preventing backbone hydration and, generally, the
concurrent total or partial denaturation of the soluble struc-
ture [13,14]. As shown in this work, this integrity is often
ensured through the formation of protein complexes, which
become more or less obligatory depending on the extent of
structure vulnerability and the level of backbone protection
provided by the association [13]. By adopting vulnerability as
a structural indicator of dosage imbalance effects, the extent
of reliance on binding partnerships is precisely quantified
and shown to be an organizing factor for the yeast and human
transcriptome.
Results
Protection of a vulnerable protein and co-expression 
demands
We start by defining vulnerability ν of a soluble protein struc-
ture as the ratio of solvent-exposed backbone hydrogen bonds
(SEBHs) to the overall number of such bonds (Figure 1). The
SEHBs may be computationally identified from atomic coor-
dinates (Materials and methods). Thus, while backbone
hydrogen bonds are determinants of the basic structural
motifs [15,16], the SEHBs represent local weaknesses of the
structure.
Figure 1a shows the vulnerability pattern of a well protected
soluble protein, the yeast SH3 signaling domain [17], with ν =
19.0%. Figure 1b shows the most vulnerable protein structure
for an autonomous folder in the Protein Data Bank (PDB) (ν
= 63.0%), the cellular form of the 90-230 fragment of the
human prion protein PrPC (PDB.1QM0) [18]. This extreme
case was detected after exhaustive computation of the ν
parameter for all conformations of isolated (those not in a
complex) polypeptide chains reported in the PDB (Materials
and methods). Figure 2 shows the most vulnerable structure
adopted by a protein chain within a yeast complex: subunit 1
from the cytochrome b-c1 complex (COR1/YBL045C).
U n l i k e l y  t o  b e  f o u n d  i n  i s o l a t ion, this structure is found
within the mitochondrial respiratory chain complex III [19].
A vulnerable soluble structure gains extra protection of its
backbone hydrogen bonds through forming complexes, as
nonpolar groups of a binding partner contribute to expel
water molecules from the microenvironment of the pre-
formed bonds [13]. On the other hand, the SEBHs promote
their own dehydration as a means to stabilize and strengthen
the hydrogen bond [14].
Hydrogen-bond pattern and structural vulnerabilities (SEBHs) of the yeast  SH3 domain and the human prion protein PrPC Figure 1
Hydrogen-bond pattern and structural vulnerabilities (SEBHs) of the yeast 
SH3 domain and the human prion protein PrPC. (a) Hydrogen-bond 
pattern and structural vulnerabilities (SEBHs) of the yeast SH3 domain 
from a S. cerevisiae 40.4 kDa protein (PDB.1SSH) [17]. The ribbon display 
is included as a visual aid. The protein backbone is shown as virtual bonds 
(blue) joining consecutive α-carbons in the peptide chain. Light-grey 
segments represent well protected backbone hydrogen bonds, and green 
segments represent SEBHs. The extent of solvent-exposure extent of a 
hydrogen bond was determined from atomic coordinates by calculating 
the number of nonpolar groups within its microenvironment (Materials 
and methods). SEBHs are those backbone hydrogen bonds protected by 
an insufficient number of nonpolar groups as statistically defined in 
Materials and methods. The level of structure vulnerability ν, defined as 
the ratio of SEBHs to the overall number of backbone hydrogen bonds, is 
19.0% (ν = 4/21). (b) SEBH-pattern for the cellular structure of the human 
prion protein PrPC (PDB.1QM0) [18]. Its vulnerability parameter is ν = 
63.0%, making it the most vulnerable soluble folder of all structures of 
unbound proteins reported in the PDB.
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To delineate the role of structure vulnerability as an organiz-
ing integrative factor in large-scale descriptions of the molec-
ular phenotype, we first examined the Pfam-filtered [7]
protein complexes for yeast [8] and human [20]. These asso-
ciations involve domains whose PDB-reported homologs are
involved in complexes.
This work quantitatively examines the relationship between
the structural vulnerability of a protein and the extent of co-
expression of genes encoding its binding partners. Thus, the
extent of co-expression, η (i, j), for two genes i, j encoding
interacting proteins is measured by the expression correla-
tion of the two genes normalized to the average correlation
over the interactome (Materials and methods). In conso-
nance, the expression correlation of a complex, η (complex),
may be defined by the maximum expression correlation over
its constitutive underlying pairwise interactions (see Addi-
tional data files 7-9 for alternative definitions).
Thus, the most highly correlated yeast complex (overall η
(complex) = 3.61) with full PDB-reported representation is
the mitochondrial respiratory chain complex III shown in
Figure 3a (PDB.1KB9[19]). The most vulnerable protein
within the complex (ν = 57%) is subunit 1 from the cyto-
chrome b-c1 complex (Gene/ORF = COR1/YBL045C, shown
in red). Its peptide chain conformation, with the SEBH pat-
tern described in Figure 2, is involved in the most highly cor-
related interaction (η  = 3.61) within the complex (Figure
3b,c). The binding partner in this interaction is subunit 2 of
cytochrome b-c1 (Gene/ORF = QCR2/YPR191W, blue chain
in Figure 3a). Figure 3c shows the mutual protection of
preformed SEBHs in the two subunits along part of their
association interface (red, COR1 residues 42-119; blue, QCR2
residues 250-331). This intermolecular mutual 'wrapping' of
local weaknesses illustrates the fact that the association con-
tributes to maintain structural integrity (Figure 3c).
We examined the role of structure vulnerability as a factor
governing the extent of co-expression of binding partners in
illustrative yeast complexes (Figure 4a; Additional data file 1).
Structure-based protein-protein interactions were curated
through the Pfam database, so that two proteins were consid-
ered to interact with each other if their respective domains (or
homolog domains) were reported in a PDB complex [8,21].
The expression correlation, η, for each interaction pair within
a complex was determined at the mRNA level of the genes
whose open reading frames (ORFs) contained the interacting
domains (Materials and methods). Vulnerabilities were com-
puted either directly from PDB files, when available, as
described in Figure 1, or from atomic coordinates generated
by homology threading using the Pfam-homolog domain as
template (Materials and methods). In the latter case, side-
chain equilibration, constrained by a fixed homology-
threaded backbone, was obtained from constrained molecu-
lar dynamics simulations (Materials and methods). We then
determined the maximum ν-value for each interactive pair
and, using the comprehensive microarray database for Sac-
charomyces cerevisiae glucose→ glycerol metabolic adapta-
tion [22], we computed the expression correlation η for each
Pfam interaction. A tight (η-ν)  correlation (R2 = 0.891) is
Ribbon representation and vulnerability (SEBH) pattern of subunit 1 from  the cytochrome b-c1 complex Figure 2
Ribbon representation and vulnerability (SEBH) pattern of subunit 1 from 
the cytochrome b-c1 complex. (a) Ribbon representation and (b) 
vulnerability (SEBH) pattern of subunit 1 from the cytochrome b-c1 
complex (PDB.1KB9) [19]. In b, red segments represent virtual protein 
backbone bonds, light-grey segments represent well protected backbone 
hydrogen bonds, and those green segments represent SEBHs. In the 
cytochrome complex, this protein adopts a highly vulnerable (ν = 57.3%) 
conformation.
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obtained and shown to hold across the illustrative yeast com-
plexes (Figure 4a) and, furthermore, to hold across all 1,354
pairs of interacting proteins in the yeast interactome with
Pfam representation (Figure 4b,c; Additional data file 2). The
(η-ν) correlation implies that the protection of a functionally
competent protein structure in yeast drives co-expression of
its binding partners to an extent that is determined by the
structure vulnerability.
In selecting the yeast transcriptome [22], particular attention
was focused on the 'perturbative' nature of the change trigger-
ing the structural remodeling of the proteomic network
across different phases. A more extensive remodeling on a
vastly larger scale, as in the complete yeast developmental
cycle [23], cannot be treated as a perturbation since it clearly
alters the modular structure of the proteome network [4] and,
consequently, yields a weaker (η-ν) correlation (Additional
data file 10).
Structure vulnerability is not only an organizing factor for the
metabolic-adaptation transcriptome but also steers the
organization of tissue-based transcriptomes. This is revealed
by a similar comparative analysis of the most comprehensive
protein-encoding gene-expression data for human [11] and
the structure-represented interactome [20]. Thus, a clear (η-
ν) correlation is apparent between the co-expression of 607
gene pairs and the maximum structure vulnerability for each
pair of interacting domains encoded in the ORFs of the
respective genes (Figure 5; Additional data file 3).
Other human transcriptomes based on normal tissue expres-
sion were examined (see, for example, [24]), but none pro-
vided statistically significant (>>10 genes pairs) representati-
on for the gene pairs for which interactome data also exist
[20], as needed for the present study.
Post-transcriptional regulation of the expression of 
highly vulnerable proteins
In contrast with the tighter yeast correlation, a few but signif-
icant outlier pairs (Figure 5, red data points) are found
beyond the confidence band defined by a width of two Gaus-
sian dispersions from the linear (η-ν) fit. To rationalize this
fact, we identified 115 human genes with ORFs encoding
extremely vulnerable proteins (Additional data file 4). Con-
sistent with the definition of structure vulnerability (Figure
1), the latter proteins are identified by large sequences (≥ 30
residues) of amino acids that are poor protectors of backbone
hydrogen bonds. In principle, a sizable window of residues
unable to protect backbone hydrogen bonds produces a poor
folder, yielding a highly vulnerable structure [14,25]. Thus,
these sequences are either probably unable to sustain a stable
soluble structure, or prone to relinquish the folding informa-
tion encoded in the amino acid sequence in favor of self-
aggregation [25]. The poor protectors (G, A, S, Y, N, Q, P) are
amino acids possessing side chains with insufficient nonpolar
groups, with polar groups too close to the backbone (thus pre-
Mutual protection of SEBHs in the two subunits of mitochondrial  respiratory chain complex III Figure 3
Mutual protection of SEBHs in the two subunits of mitochondrial 
respiratory chain complex III. (a) Ribbon representation of mitochondrial 
respiratory chain complex III (PDB.1KB9). The high structure vulnerability 
of subunit 1 (red; compare Figure 2) renders it highly needy for interaction 
with other subunits of the complex to maintain its structural integrity. (b) 
SEBH pattern for subunit 1 (red) and subunit 2 (blue). The interacting pair 
is characterized by a very high expression correlation η = 3.61. The yellow 
square highlights the part of the interface shown in detail in (c). (c) 
Illustration of mutual protections of SEBHs in the two subunits along part 
of their interface. One side-chain bond (between α and β carbons) is 
displayed. The thin blue lines, which connect β-carbons in one protein 
with centers of hydrogen bonds in the other protein, represent mutual 
protections of hydrogen bonds across the protein-association interface. 
Thus, a thin line is shown whenever the side chain of one protein is 
contributing with nonpolar groups to the microenvironment of a 
preformed hydrogen bond in its binding partner.
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Color       Pfam Gene ORF
Red         Peptidase_M16             COR1 YBL045C
Blue        Peptidase_M16             QCR2 YPR191W
Green     Cytochrom_B_C COB Q0105
White      Cytochrom_C1              CYT1 YOR065W
Purple     UCR_TM                       RIP1 YEL024W
Orange    UCR_14kD                   QCR7 YDR529C
Cyan       UcrQ QCR8 YJL166W
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cluding hydrogen-bond protection through clustering of non-
polar groups) [14] or with amphiphilic aggregation-
nucleating character (Y) [26-28]. Charged backbone de-pro-
tecting side chains (D, E) are excluded since they would entail
negative design relative to protein self-aggregation. All out-
lier interactions in the human (η-ν) correlation involve genes
with extreme vulnerability (Figure 5; Additional data file 4).
Significantly, when the same criterion for extreme vulnerabil-
ity is used to scan the yeast genome (Additional data file 5), 85
genes are identified whose ORFs encode the five confirmed
prion proteins for this organism [26-29]: PSI+ (SUP35), NU+
(NEW1), PIN+ (RNQ1), URE3 (URE2) and SWI+ (SWI1).
This fact is statistically significant (P < 10-10, hypergeometric
test) and supports the presumed relationship between struc-
tural vulnerability of the soluble fold and aggregation propen-
sity [25].
The  (η-ν)  correlation reported in Figure 5 for human is
weaker than the yeast counterpart likely because, in contrast
with yeast, mRNA levels are not a reliable surrogate for pro-
tein expression levels in human [30,31]. This observation led
us to examine post-transcriptional regulation in human
genes, to analyze the microRNA (miRNA) targeting of the
predicted 115 extremely vulnerable human genes (Additional
Correlation between maximum structure vulnerability ν and co-expression similarity η for yeast protein interactions Figure 4
Correlation between maximum structure vulnerability ν and co-expression similarity η for yeast protein interactions. (a) Correlation between maximum 
structure vulnerability ν and co-expression similarity η for interactions within specific yeast complexes. The ν-parameter of an interaction is defined as the 
maximum vulnerability between the two interacting partners, and the η-parameter is the ratio of their expression correlation to the (non-zero) expected 
correlation over all interacting pairs in the proteome. (b) (η-ν) correlation for all Pfam-filtered yeast protein interactions. Red points represent 
interactions involving extremely vulnerable proteins, including confirmed yeast prions (Additional data file 5). (c) (η-ν) correlation of Pfam-filtered yeast 
protein interactions involving only PDB-reported proteins. The red data point represents an interaction involving an extremely vulnerable protein, and the 
green point represents an interaction involving an extremely vulnerable protein reported to be a prion protein (ERF2) [24-26].
R
2 = 0.9072
0
10
20
30
40
50
60
70
80
-4 -3 -2 -1 0 1 2 3 4
expression correlation,  η
s
t
r
u
c
t
u
r
e
 
v
u
l
n
e
r
a
b
i
l
i
t
y
,
 
ν
(c)
(b) (a)
R
2 = 0.8905
0
10
20
30
40
50
60
70
80
-4 -3 -2 -1 0 1 2 3 4
expression correlation,  η
s
t
r
u
c
t
u
r
e
 
v
u
l
n
e
r
a
b
i
l
i
t
y
,
 
ν
0
10
20
30
40
50
60
70
80
- 4 - 3 - 2 - 101234
expression correlation,  η
s
t
r
u
c
t
u
r
e
 
v
u
l
n
e
r
a
b
i
l
i
t
y
,
 
ν
DNA-directed RNA polymerase I complex
DNA-directed RNA polymerase II, holoenzyme
DNA-directed RNA polymerase II, core complex
DNA-directed RNA polymerase III complex
ribosome
proteasome complex (sensu Eukaryota)Genome Biology 2008, 9:R107
http://genomebiology.com/2008/9/7/R107 Genome Biology 2008,     Volume 9, Issue 7, Article R107       Chen et al. R107.6
data files 4 and 6), and to contrast the miRNA-targeting sta-
tistics with the generic values across the human genome [31].
To obtain statistics on miRNA targeting, we identified
putative target sites in the 3' UTR (untranslated region) of
each gene for 162 conserved miRNA families (Materials and
methods) [31]. Thus, 7,927 out of 17,444 genes (45.4%) are
(η - ν) correlation for human protein interactions Figure 5 
(η - ν) correlation for human protein interactions. (a) The (η-ν) correlation for all Pfam-filtered human protein interactions. Red points represent 
interactions involving extremely vulnerable proteins (Additional data file 4). (b) The correlation over Pfam-filtered human protein interactions that involve 
only PDB-reported proteins. The red point represents an interaction containing an extremely vulnerable protein.
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predicted to contain at least one miRNA target site (Addi-
tional data file 6), while 87 out of 105 (82.9%) extremely vul-
nerable genes are predicted to be targeted genes. Thus,
human genes containing extremely vulnerable regions are
more frequently targeted by miRNA (P << 1.31 × 10-5, bino-
mial test). In regards to miRNA regulation complexity, the
mean number of miRNA target sites for human genes is 2.66
and the median is 0, while the mean number for extremely
vulnerable genes is 6.01 and the median is 5. This significant
difference (P < 10-16, Wilcox rank test) strongly suggests that
the deviation of extremely vulnerable genes from the (η-ν)
correlation (Figure 5), with expression correlation evaluated
at the level of mRNA expression, can be explained by post-
transcriptional miRNA regulation. This type of regulation
influences the final protein expression level. In a broad sense,
this analysis highlights the connection between protein struc-
ture and gene regulation: extremely vulnerable genes require
tight control at the post-transcriptional level.
Protein intrinsic disorder and transcriptome 
organization
The inability of an isolated protein fold to protect specific
intramolecular hydrogen bonds from water attack may lead
to structure-competing backbone hydration with concurrent
local or global dismantling of the structure [14,25,32]. This
view of structural vulnerability suggests a strong correlation
between the degree of solvent exposure of intramolecular
hydrogen bonds and the local propensity for structural disor-
der [33-35]: in the absence of binding partners, the inability
of a protein domain to exclude water intramolecularly from
pre-formed hydrogen bonds may be causative of a loss of
structural integrity, and this t e n d e n c y  i s  m a r k e d  b y  t h e
disorder propensity of the domain [32]. These findings led us
to regard the predicted extent of disorder in a protein domain
as a likely surrogate for its vulnerability and to contrast it with
the extent of expression correlation with its interactive part-
ners. The disorder propensity may be determined by a
sequence-based score, fd(fd = 1, certainty of disorder; fd = 0,
certainty of order), assigned to each residue. In this work, this
parameter is generated by the highly accurate predictor of
native disorder PONDR-VSL2 [34,35]. The extent of intrinsic
disorder of a domain may be defined as the percentage of res-
idues predicted to be disordered relative to a predetermined
fd threshold (fd = 0.5).
Reexamination of the expression correlations in the yeast and
human transcriptomes was carried out, taking into account a
proteome-wide sequence-based attribution of the extent of
disorder (percentage of residues predicted to be disordered,
or 'disorder content') in interacting protein domains. The dis-
order predictions did not include any structural information
on induced fits arising upon forming a complex, and hence,
unlike structure vulnerability, the percent predicted disorder
is independent of the complex under consideration. This fact
introduces deviations in the estimation of vulnerability
through disorder content for proteins with extensive disorder
content since their conformational plasticity may enable
diverse induced-fit conformations with different vulnerabilit-
ies (Figure 6a). In yeast, the extent of disorder of the most dis-
ordered domain for each pair of interacting domains captures
the degree of correlation in the expression patterns required
for structure protection (Figure 6a). This is revealed by the
correlation between the extent of disorder of the most disor-
dered domain in an interacting pair and the expression corre-
lation η of the two genes encoding the respective interacting
domains. While weaker than the η-ν correlation (Figure 4),
the η-disorder correlation is still relatively strong for yeast
proteins (R2 = 0.752; Figure 6a), implying that disorder con-
tent determines the degree of coexpression of binding part-
ners to a significant extent. The large dispersion in disorder
extent at high levels of coexpression (approximately 45% dis-
persion versus approximately 15% for proteins with low dis-
order/low expression correlation) is indicative that highly
disordered chains may adopt structures with very different
levels of vulnerability depending on the complex in which
they are involved (the η-ν correlation does not widen so sig-
nificantly for smaller η-values). Thus, the more disordered
the chain, the more multi-valued the correspondence
between disorder extent and vulnerability, conferring higher
dispersion to the η-disorder correlat- ion.
The η-disorder correlation in human is considerably weaker
(R2 = 0.304; Figure 6b) than in yeast. This is partly due to the
fact that human proteins have a higher degree of disorder
propensity than their yeast orthologs [36] and, hence, they
are capable of significantly diversifying their structural adap-
tation (induced folding) in different complexes. In this con-
text, the extent of disorder becomes a poor surrogate of
structural vulnerability, as different ν-values may correspond
to a single percent predicted disorder. In addition, post-tran-
scriptional regulation in humans implies that expression cor-
relations at the mRNA level are not reflective of the protein
concurrencies modulated by tissue type, as indicated above.
To conclude, Figure 6 reveals the role of intrinsic protein dis-
order in transcriptome organization suggested by exploring
the interrelationship between protein vulnerability and disor-
der propensity.
Discussion
Soluble protein structures may be more or less vulnerable to
water attack depending on their packing quality. As shown in
this work, one way of quantifying the structure vulnerability
is by determining the extent of solvent exposure of backbone
hydrogen bonds. Within this scheme, local weaknesses in the
protein structure may become protected upon forming a com-
plex, as exposed backbone hydrogen bonds become exoge-
nously dehydrated. Vulnerable structures are thus quantitati-
vely reliant on binding partnerships to maintain their integ-
rity, suggesting that vulnerability may be regarded as a struc-
ture-based indicator of gene dosage sensitivity [37,38]. ThisGenome Biology 2008, 9:R107
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observation is validated by establishing the significance of
protein vulnerability or structure protection as an organizing
factor in temporal phases (yeast) and tissue-based (human)
transcriptomes. Specifically, this role was established by
examining the degree of co-expressions of a protein with its
binding partners in structure-represented interactions. Thus,
(η-disorder) correlation for yeast and human protein interactions Figure 6
(η-disorder) correlation for yeast and human protein interactions. Correlation between η-parameter and percent predicted disorder (disorder content) 
of the most disordered domain for each of (a) the 1,354 Pfam-filtered protein-interaction pairs in yeast and (b) the 607 pairs in human.
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for each Pfam-filtered binding partnership, the extent of co-
expression across metabolic adaptation phases (yeast) or tis-
sue types (human) was found to depend quantitatively on the
structure vulnerability of the proteins involved. Hence, vul-
nerability may be regarded as an organizing factor encoded in
the structure of gene products.
Furthermore, as shown in this work, the tight coordination
between translation regulation and gene function dictates
that extremely vulnerable, and hence 'highly needy', proteins
are subject to significant levels of post-transcriptional regula-
t i o n .  I n  h u m a n ,  t h i s  e x t r a  r e g u l a t i o n  i s  a c h i e v e d  t h r o u g h
extensive miRNA targeting of genes coding for extremely vul-
nerable proteins. In yeast, on the other hand, our results
imply that such a regulation is likely achieved through
sequestration of the extremely vulnerable proteins into aggre-
gated states. Intriguingly, the 85 yeast genes encoding
extremely vulnerable proteins included those for the five con-
firmed yeast prions [26-29]. This statistically significant
result implies that if the extremely vulnerable proteins are
themselves translational regulators, this sequestration may
directly lead to epigenetic consequences and phenotypic pol-
ymorphism [26-28].
Conclusion
In this work we adopted a structural biology perspective to
reassess the fundamental notion of 'dosage imbalance effect'
and examine the implications for gene expression, specifically
for transcriptomal organization and post-transcriptional reg-
ulation. Thus, vulnerability of protein structures and the
concurrent need to maintain structural integrity for func-
tional reasons prove to be quantifiers of dosage imbalance:
proteins with a high degree of reliance on binding partner-
ships to maintain their structural integrity are naturally
expected to yield high dosage sensitivity in their respective
gene expressions. Hence, structural vulnerability is shown to
be a determinant of transcriptome organization across tissues
and temporal phases: the need for protein structure
protection compels gene co-expression in a quantifiable man-
ner. Extreme vulnerability is shown to require significant
additional regulation at the post-transcriptional level, mani-
fested by epigenetic aggregation in yeast and miRNA target-
ing in human. These latter observations will likely inspire
further study of structure-encoded signals that govern post-
transcriptional regulation.
Materials and methods
Expression data sources
Yeast expression data were obtained from the comprehensive
Saccharomyces Genome Database [22]. This complete data-
set contains mRNA expression levels during a transition from
glucose-fermentative to glycerol-based respiratory growth.
Human expression data were taken from the comprehensive
Novartis Gene Expression Atlas [11]. This dataset includes
158 array images composed of 79 samples, each of which has
two replicates hybridized on the human genome HG-U133A
array. We discarded six samples of cancer tissues: Colorecta-
lAdenocarcinoma, leukemialymphoblastic(molt4), lympho-
maburkittsRaji, leukemiapromyelocytic, lymphomaburkitts
Daudi, and leukemiachronicmyelogenous (k562).
Interaction data sources
Protein interaction curation based on structure provides
direct physical interactions [8]. Two proteins were consid-
ered to interact with each other when their respective
domains or homologs of their respective domains were found
in a complex with PDB-reported structure. We obtained
curated yeast protein domain interactions from the Structural
Interaction Network [8], and filtered them using recently
published yeast interaction data [21]. For human, we focused
on interactions within complexes. The complex data were
obtained from the MIPS/Mammalian Protein Complex Data-
base [20]. We used the protein domain descriptions in the
Pfam database [7], and searched for domain-domain interac-
tions using iPfam [39].
Expression correlation η
The expression correlation for a protein-protein interaction is
a normalized quantity defined as the Pearson correlation of
the expression vectors of the genes encoding for the interact-
ing domains divided by the mean correlation over all gene
pairs encoding for interacting domains. The normalization is
necessary for comparative analysis across species because
different species have different mean expression correlations
and, hence, the significance of a correlation is necessarily a
relative attribute. Given its statistical nature, the denomina-
tor is non-zero for any species since, in a statistical sense, pro-
tein pairs that interact are expected to be positively correlated
in their expression. We use the Pearson correlation coeffi-
cients of expression vectors to determine similarity between
expression profiles. For two expression vectors X and Y, the
Pearson correlation coefficient Corr(X, Y) is given by:
where X, Y are generic coordinates in the vectors X and Y,
respectively, and < > indicates mean over the 73 normal tis-
sues (human) [11] or over the 5 metabolic adaptation phases
(yeast) [22].
Calculation of vulnerability ν and identification of 
SEBHs for soluble proteins
To determine the extent of solvent exposure of a backbone
hydrogen bond in a soluble protein structure, we determine
the extent of bond protection from atomic coordinates. This
parameter, denoted ρ, is given by the number of side-chain
nonpolar groups contained within a desolvation domain
(hydrogen-bond microenvironment) defined as two inter-
secting balls of fixed radius (the approximate thickness of
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three water layers) centered at the α-carbons of the residues
paired by the hydrogen bond. In structures of PDB-reported
soluble proteins, at least two-thirds of the backbone hydrogen
bonds are protected on average by ρ = 26.6 ± 7.5 side-chain
nonpolar groups for a desolvation ball radius of 6 Å. Thus,
SEBHs lie in the tails of the distribution, that is, their micro-
environment contains 19 or fewer nonpolar groups, so their ρ-
value is below the mean (ρ = 26.6) minus one standard devi-
ation (= 7.5).
In cases where the protein structures were unavailable from
the PDB, we generated atomic coordinates through homology
threading adopting the Pfam homolog as template and using
the program Modeller [40-42]. Modeller is a computer pro-
gram that models three-dimensional structures of proteins
subject to spatial constraints [40], and was adopted for
homology and comparative protein structure modeling. We
thus generate the alignment of the target sequence to be mod-
eled with the Pfam-homolog structure reported in the PDB
and the program computes a model with all non-hydrogen
atoms. The input for the computation consists of the set of
constraints applied to the spatial structure of the amino acid
sequence to be modeled and the output is the three-dimen-
sional structure that best satisfies these constraints. The
three-dimensional model is obtained by optimization of a
molecular probability density function with a variable target
function procedure in Cartesian space that employs methods
of conjugate gradients and molecular dynamics with simu-
lated annealing.
Homolog PDB sources
Yeast PDB homologs were obtained from the Saccharomyces
Genome Database [43], and human PDB homologs were from
Pfam [44].
Micro-RNA targeting analysis
For 17,444 human genes, we identified putative target sites
for 162 conserved miRNA families using TargetScanS
(version 4.0), a leading target-prediction program [45]. Thus,
we obtained the number of target-site types in the 3' UTR of
each gene [31]. Among the genes in our analysis: 105 genes
were identified as encoding extremely vulnerable proteins;
7,927 out of 17,444 genes (45.4%) are predicted to be miRNA
targets (containing at least one type of miRNA target site);
and 87 out of 105 genes encoding extremely vulnerable pro-
teins (82.9%) are predicted to be target genes. Thus, genes
encoding extremely vulnerable proteins tend to be miRNA
target genes (P << 1.31 × 10-5, binomial test).
In terms of miRNA regulation complexity, the average
number of miRNA target-site types for a human gene is 2.66
and the median number is 0; while the average number for a
prion gene is 6.01 and the median is 5. Again, this is highly
significant (P < 10-16, Wilcox rank test).
Prediction of native disorder of protein domains
The highly accurate predictor of native disorder PONDR
VSL2 [34,35] exploits the length-dependent (heterogenous)
amino acid compositions and sequence properties of intrinsi-
cally disordered regions to improve prediction performance.
Unlike previous PONDR predictors for long disordered
regions (>30 residues), it is applicable to disordered regions
of any length. The disorder score (0 ≤ fd ≤ 1) is assigned to each
residue within a sliding window, representing the predicted
propensity of the residue to be in a disordered region (fd = 1,
certainty of disorder; fd = 0, certainty of order). The disorder
propensity is quantified by a sequence-based score that takes
into account residue attributes such as hydrophilicity, aroma-
ticity, and their distribution within the window interrogated.
Abbreviations
miRNA, micro RNA; ORF, open reading frame; PDB, Protein
Data Bank; SEBH, solvent-exposed backbone hydrogen
bonds; UTR, untranslated region.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 provides raw data
for Figure 4a. Additional data file 2 provides Raw data for Fig-
ure 4b,c. Additional data file 3 provides raw data for Figure 5.
Additional data file 4 lists extremely vulnerable proteins in
human. Additional data file 5 lists extremely vulnerable yeast
proteins. Additional data file 6 lists the predicted number of
miRNA targets for human genes. Additional data file 7 out-
lines the robustness of results with respect to alternative
graph-theoretic definitions of co-expression similarity. Addi-
tional data file 8 outlines how vulnerability correlates with co-
expression similarity in protein complexes. Additional data
file 9 provides Raw data: yeast (a) and human (b) complexes
examined in Additional data file 8. Additional data file 10
shows the (η-ν) plot obtained for the yeast developmental-
phase transcriptome obtained from a comprehensive identifi-
cation of cell cycle-regulated genes by microarray hybridiza-
tion [23].
Additional data file 1 Raw data for Figure 4a Data in column A indicate the expression correlation η associated  with protein interactions, and data in column B indicate the struc- ture vulnerability ν for interactions within specific complexes. The  rest of the columns contain the ORF, domain and structure infor- mation (PDB accession code of interacting domain or its Pfam- homologs), respectively, for every pair of interacting proteins. Click here for file Additional data file 2 Raw data for Figure 4b,c Sheet 1 contains all Pfam-filtered yeast protein interactions, while  sheet 2 contains only those interactions with both partners having  PDB structures. In each sheet, column A lists the expression corre- lation h of interactions, and columns B and C list the structure vul- nerability n of interactions not involving or involving, respectively,  extremely vulnerable proteins. The remaining columns contain  ORF, domain and structure information (PDB accession code of  interacting domain or of its Pfam-homologs) for every pair of inter- acting proteins. Click here for file Additional data file 3 Raw data for Figure 5 Sheet 1 contains all Pfam-filtered human protein interactions,  while sheet 2 contains only those interactions with both partners  having PDB structures. In each sheet, column A contains the  expression correlation h for each interaction, and columns B and C  list the structure vulnerability n of interactions not involving or  involving, respectively, extremely vulnerable proteins, and the rest  of the columns list gene name, protein ID, domain and structure  information (PDB accession code of interacting domain or of its  Pfam-homologs) of every pair of interacting proteins. Click here for file Additional data file 4 Extremely vulnerable proteins in human The extremely vulnerable proteins in human are identified from  genome-wide scanning of protein-encoding regions with sequence  windows (length ≥ 30) containing mainly amino acids (G, A, S, Y,  N, Q, P) that are poor protectors of the protein backbone. An  extremely vulnerable protein contains at least one such window  with a threshold of three amino acids allowed to be outside the  group of poor protectors. Click here for file Additional data file 5 Extremely vulnerable yeast proteins Extremely vulnerable yeast proteins are determined in the same  way as for human (Additional data file 4). The rows marked in  green correspond to the five confirmed yeast prions [26-29]:  SUP35 (ERF2), URE2, NEW1, RNQ1 and SWI1. Click here for file Additional data file 6 Predicted number of microRNA targets for human genes The number of putative target-site types corresponding to 162 con- served miRNA families determined for 17,444 human genes by  interrogation of the 3' UTR using TargetScanS (version 4.0) [45]. Click here for file Additional data file 7 Robustness of results with respect to alternative graph-theoretic  definitions of co-expression similarity The co-expression similarity for genes i, j, encoding a pair of inter- acting proteins is alternatively measured as the adjacency aij(β) =  (0.5 + 0.5 η (i, j))β, where η (i, j) is the expression correlation for the  gene pair i, j and β is a soft threshold [46]. Similarly, the structure  vulnerability is alternatively defined as νi, j(β) = ν (i, j)β, where ν (i,  j) is the maximum ν-value for the interacting pair. (a, b) (ν (β)- a(β)) correlations for yeast for exponents β = 0.5 (a) and 10 (b). The  adjacencies for β = 1 correspond simply to a linear rescaling of η  already correlated with ν in Figure 4. (c, d) The same as (a, b) but  for human. Notice that high exponents (β > 1) tend to amplify dif- ferences in co-expression, yielding lower correlation coefficients  (R2 in (ν (β)-a(β)) plots). Click here for file Additional data file 8 Vulnerability correlates with co-expression similarity in protein  complexes A normalized co-expression similarity γ (β, complex) for all genes  encoding proteins that form a complex is obtained from the adja- cencies of the pairwise interactions within the complex as: γ (β,  complex) = [mediani, j ∈ complexaij(β)]/mediani, j aij(β)], where the  median in the denominator extends over all interactive pairs in the  interactome. Similarly, the normalized structure vulnerability Λ (β,  complex) for complexes is defined as Λ (β, complex) = [mediani, j ∈  complexνij(β)]/mediani, j νij(β)]. (a-c) (Λ (β, complex)-γ (β, complex))  correlation over all 98 yeast complexes with transcriptome repre- sentation for exponents β = 0.5 (a), 1 (b) and 10 (c). (d-f) The same  as (a-c) but for 53 human complexes. Click here for file Additional data file 9 Raw data for yeast and human complexes examined in Additional  data file 8 (a) Yeast complexes. (b) Human complexes. Click here for file Additional data file 10 (η-ν) plot obtained for the yeast developmental-phase transcrip- tome obtained from a comprehensive identification of cell cycle- regulated genes by microarray hybridization (η-ν) plot obtained for the yeast developmental-phase transcrip- tome obtained from a comprehensive identification of cell cycle- regulated genes by microarray hybridization [23] Click here for file
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